ZBIO Stock Analysis: Buy, Sell, or Hold?
ZBIO - Zenas BioPharma, Inc. Common Stock
$18.12
-0.23 (-1.23%)
βΌ
5d:
-11.2%
30d:
-16.98%
90d:
-32.33%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 21, 2026
2d
Get Alerted When ZBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: ZBIO is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: ZBIO is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZBIO is currently trading at $18.11, which is considered oversold relative to its 30-day fair value range of $18.62 to $21.13.
Technical Outlook: Technically, ZBIO is in a downtrend. Immediate support is located at $17.39, while resistance sits at $22.15.
Market Sentiment: ZBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.12 (+129.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZBIO is in a downtrend. Immediate support is located at $17.39, while resistance sits at $22.15.
Market Sentiment: ZBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.12 (+129.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.62 -
$21.13
Company Quality Score
54/100
(HOLD)
Options IV Signal
44th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding ZBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 44th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 129.7% below Wall St target ($42.12)
- WARNING: Recommendation downgraded due to -11.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$18.62 -
$21.13
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
Β±$3.01
(16.6%)
Support & Resistance Levels
Support Level
$17.39
Resistance Level
$22.15
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-96.53
Wall Street Target
$42.13
(+129.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: May 18, 2026 10:11 AM ET
Data refreshes hourly during market hours. Next update: 11:11 AM
Data refreshes hourly during market hours. Next update: 11:11 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBIO showing a specific setup today?
Insider Activity (6 Months)
9
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Fairmount Funds Managemeβ¦
BUY
150000 shares
2026-03-31
Hongbo Lu
BUY
3768 shares
2026-03-31
Patricia L Allen
BUY
4160 shares
2026-02-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut⦠|
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
Advanced ZBIO Option Strategies
Professional options setups generated by AI based on today's ZBIO price and gamma walls.